Session Name: Pharmacological Management of Diabetes

Time: October 23, 2024

We appreciate your time and effort in participating in this CME Sessional Evaluation. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

*
*
Did/Will you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Highlight the first-line medication and how to select second line glucose lowering medications for type 2 diabetics recommended by the American Diabetes Association
Relate an alteration of pathophysiology causing hyperglycemia in Type 2 diabetes to a class of medications that have a mechanism of action that counteracts it
Give an example of why to hold an oral antidiabetic medication for a patient being admitted to the hospital
Develop an inpatient insulin plan for a diabetic patient.
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
Sabahat Ali, PA-C, MPAS
Sara Hoffman, PharmD
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias